Chronic inflammatory demyelinating polyneuropathy and ventilatory failure: Report of seven new cases and review of the literature

Acta Neurologica Scandinavica

Volumn 124, Issue 1, 2011, Pages 59-63

  Zivkovic S A ^a,b   Peltier, A C ^c   Iacob, T ^d   Lacomis, D ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d Gottlieb Memorial Hospital   (United States)

Author keywords

Chronic inflammatory demyelinating polyneuropathy; Phrenic nerve; Ventilatory failure

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; MYCOPHENOLIC ACID; PREDNISONE;

ADULT; AGED; APHERESIS; ARTIFICIAL VENTILATION; CAUSE OF DEATH; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONVALESCENCE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REDUCTION; ELECTRODIAGNOSIS; FEMALE; GUILLAIN BARRE SYNDROME; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LIMB WEAKNESS; MALE; MUSCLE FATIGUE; NERVE BIOPSY; NOTE; RECURRENT DISEASE; RELAPSE; RESPIRATORY FAILURE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES;

EID: 79958280802     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2010.01431.x     Document Type: Note

References (22)

1. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989;46:878-84.
2. Gorson KC, Allam G, Ropper AH. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 1997;48:321-8.
3. Oh SJ, Kurokawa K, De Almeida DF, Ryan HF Jr, Claussen GC. Subacute inflammatory demyelinating polyneuropathy. Neurology 2003;61:1507-12.
4. Dionne A, Nicolle MW, Hahn AF. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy. Muscle Nerve 2010;41:202-7.
5. Macia F, Le Masson G, Rouanet-Larriviere M et al. A prospective evaluation of phrenic nerve conduction in multifocal motor neuropathy and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2003;28:319-23.
6. Cocito D, Ciaramitaro P, Rota E et al. Subclinical electrophysiological alterations of phrenic nerve in chronic inflammatory demyelinating polyneuropathy. J Neurol 2005;252:916-20.
7. Kimber TE, Orrell RW, King RH, Ginsberg L. Pathological findings in a patient with ventilatory failure and chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 2003;8:13-6.
8. Sasaki M, Ohara S, Oide T, Hayashida K, Hayashi R. An autopsy case of chronic inflammatory demyelinating polyradiculoneuropathy with respiratory failure. Muscle Nerve 2004;30:382-7.
9. Stojkovic T, De Seze J, Hurtevent JF, Fourrier F, Vermersch P. Phrenic nerve palsy as a feature of chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2003;27:497-9.
10. Henderson RD, Sandroni P, Wijdicks EF. Chronic inflammatory demyelinating polyneuropathy and respiratory failure. J Neurol 2005;252:1235-7.
11. Hantson P, Kevers L, Fabien N, Van Den Bergh P. Acute-onset chronic inflammatory demyelinating polyneuropathy with cranial nerve involvement, dysautonomia, respiratory failure, and autoantibodies. Muscle Nerve 2010;41:423-6.
12. Berger AR, Bradley WG, Brannagan TH et al. Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 2003;8:282-4.
13. Anonymous. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 2005;10:220-8.
14. Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke 1988;19:1497-500.
15. Costa J, De Carvalho M. Chronic inflammatory demyelinating polyneuropathy, phrenic nerve and respiratory symptoms. Eur J Neurol 2005;12:64-6.
16. Laughlin RS, Dyck PJ, Melton LJ 3rd, Leibson C, Ransom J. Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurology 2009;73:39-45.
17. Bouchard C, Lacroix C, Plante V et al. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 1999;52:498-503.
18. Odaka M, Yuki N, Hirata K. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barre syndrome. J Neurol 2003;250:913-6.
19. Kuitwaard K, Van Koningsveld R, Ruts L, Jacobs BC, Van Doorn PA. Recurrent Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 2009;80:56-9.
20. Kuitwaard K, Van Der Pol WL, Ruts L, Van Doorn PA. Individual patients who experienced both Guillain-Barre syndrome and CIDP. J Peripher Nerv Syst 2009;14:66-8.
21. Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain-Barre syndrome: incidence and mortality rates in US hospitals. Neurology 2008;70:1608-13.
22. Hughes RA, Wijdicks EF, Barohn R et al. Practice parameter: immunotherapy for Guillain-Barre syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2003;61:736-40.